发明公开
EP2281817A1 SUBSTITUTED CARBINOL COMPOUND HAVING CYCLIC LINKER
审中-公开
SUBSTITUIERTE CARBINOLVERBINDUNG MIT ZYKLISCHEM BINDER
- 专利标题： SUBSTITUTED CARBINOL COMPOUND HAVING CYCLIC LINKER
- 专利标题（中）： SUBSTITUIERTE CARBINOLVERBINDUNG MIT ZYKLISCHEM BINDER
-
申请号： EP09754469.6申请日： 2009-05-29
-
公开(公告)号： EP2281817A1公开(公告)日： 2011-02-09
- 发明人: YAMAGUCHI, Yuki , KOURA, Minoru , KUROBUCHI, Sayaka , MATSUDA, Takayuki , OKUDA, Ayumu , SUMIDA, Hisashi , WATANABE, Yuichiro , ENOMOTO, Takashi , SHIBUYA, Kimiyuki
- 申请人： Kowa Company, Ltd.
- 申请人地址： 6-29, Nishiki 3-chome Naka-ku Nagoya-shi, Aichi-ken 460-8625 JP
- 专利权人： Kowa Company, Ltd.
- 当前专利权人： Kowa Company, Ltd.
- 当前专利权人地址： 6-29, Nishiki 3-chome Naka-ku Nagoya-shi, Aichi-ken 460-8625 JP
- 代理机构： HOFFMANN EITLE
- 优先权： US57070 20080529
- 国际公布： WO2009144961 20091203
- 主分类号： C07D233/72
- IPC分类号： C07D233/72 ; A61K31/4166 ; A61K31/4178 ; A61K31/4355 ; A61K31/4439 ; A61K31/444 ; A61K31/506 ; A61P3/06 ; A61P3/10 ; A61P9/10 ; A61P17/00 ; A61P25/28 ; A61P29/00 ; A61P43/00 ; C07D401/04 ; C07D401/06 ; C07D401/12 ; C07D401/14 ; C07D403/04 ; C07D405/04
摘要：
It is to provide a novel LXRβ agonist that is useful as a preventative and/or therapeutic agent for atherosclerosis; arteriosclerosis such as those resulting from diabetes; dyslipidemia; hypercholesterolemia; lipid-related diseases; inflammatory diseases that are caused by inflammatory cytokines; skin diseases such as allergic skin diseases; diabetes; or Alzheimer's disease.
It is a carbinol compound represented by the following general formula (I) or salt thereof, or their solvate.
It is a carbinol compound represented by the following general formula (I) or salt thereof, or their solvate.
信息查询
